John A. Ligon

960 total citations
32 papers, 215 citations indexed

About

John A. Ligon is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, John A. Ligon has authored 32 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in John A. Ligon's work include CAR-T cell therapy research (12 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Streptococcal Infections and Treatments (4 papers). John A. Ligon is often cited by papers focused on CAR-T cell therapy research (12 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Streptococcal Infections and Treatments (4 papers). John A. Ligon collaborates with scholars based in United States, United Kingdom and Israel. John A. Ligon's co-authors include Nirali N. Shah, Bonnie Yates, J. Chase McNeil, Sheldon L. Kaplan, Kristina G. Hultén, Edward O. Mason, Haneen Shalabi, Daniel W. Lee, Toni Foley and Alexander Ling and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PEDIATRICS.

In The Last Decade

John A. Ligon

24 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Ligon United States 10 105 53 41 34 28 32 215
Priti Tewari United States 8 117 1.1× 38 0.7× 28 0.7× 65 1.9× 42 1.5× 47 235
Kathryn A. Culos United States 7 109 1.0× 27 0.5× 56 1.4× 36 1.1× 26 0.9× 17 293
Kirsten M Boughan United States 7 146 1.4× 26 0.5× 54 1.3× 64 1.9× 21 0.8× 35 263
Lynette Chee Australia 9 97 0.9× 31 0.6× 57 1.4× 65 1.9× 29 1.0× 29 320
Karamjeet Sandhu United States 11 110 1.0× 128 2.4× 73 1.8× 33 1.0× 14 0.5× 49 366
Rafael Hernani Spain 10 243 2.3× 19 0.4× 34 0.8× 40 1.2× 56 2.0× 32 343
Chu Ri Shin United States 6 114 1.1× 35 0.7× 49 1.2× 85 2.5× 139 5.0× 13 299
Chan Liao China 10 164 1.6× 57 1.1× 71 1.7× 153 4.5× 44 1.6× 29 416
Mai Abdel Haleem Abusalah Malaysia 8 84 0.8× 26 0.5× 59 1.4× 34 1.0× 14 0.5× 21 264
Alan J. Ross United Kingdom 8 44 0.4× 25 0.5× 84 2.0× 39 1.1× 10 0.4× 17 330

Countries citing papers authored by John A. Ligon

Since Specialization
Citations

This map shows the geographic impact of John A. Ligon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Ligon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Ligon more than expected).

Fields of papers citing papers by John A. Ligon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Ligon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Ligon. The network helps show where John A. Ligon may publish in the future.

Co-authorship network of co-authors of John A. Ligon

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Ligon. A scholar is included among the top collaborators of John A. Ligon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Ligon. John A. Ligon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ligon, John A., et al.. (2025). Revisiting CDKN2A dysregulation in Ewing sarcoma. Molecular Oncology. 19(4). 994–1001. 1 indexed citations
2.
Steineck, Angela, Elad Jacoby, Allison Barz Leahy, et al.. (2025). Access to CARe: A Narrative of Real‐World Medical Decision‐Making to Access Chimeric Antigen Receptor (CAR) T‐Cell Therapy in Children, Adolescents, and Young Adults. Pediatric Blood & Cancer. 72(4). e31516–e31516.
3.
Cañete‐Gibas, Connie, et al.. (2024). Cutaneous Lagenidium deciduum infection in a patient with relapsed acute myeloid leukemia. BMC Infectious Diseases. 24(1). 515–515.
4.
Ligon, John A., Margaret Cupit-Link, Christine Yu, et al.. (2024). Pediatric Cancer Immunotherapy and Potential for Impact on Fertility: A Need for Evidence-Based Guidance. Transplantation and Cellular Therapy. 30(8). 737–749. 1 indexed citations
5.
Horn, Biljana, Michael Joyce, Kevin O. McNerney, et al.. (2024). The role of donor type and pre‐transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia. Pediatric Transplantation. 28(4). e14784–e14784.
6.
Duncan, Brynn B., Sara Silbert, Bonnie Yates, et al.. (2024). Initial Experience with CD19/CD22 BiCistronic CAR T-Cells in Children and Young Adults with Recurrent or Refractory B-Cell Malignancies. Blood. 144(Supplement 1). 680–680.
8.
Ogando‐Rivas, Elizabeth, John A. Ligon, Linchun Jin, et al.. (2023). Bioconjugated liquid-like solid enhances characterization of solid tumor - chimeric antigen receptor T cell interactions. Acta Biomaterialia. 172. 466–479. 9 indexed citations
9.
Ligon, John A., Sneha Ramakrishna, Francesco Ceppi, et al.. (2023). INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies—Established Findings and Future Priorities. Transplantation and Cellular Therapy. 30(2). 155–170. 2 indexed citations
10.
Ghiaseddin, Ashley, Maryam Rahman, Dingpeng Zhang, et al.. (2023). CTIM-11. MRNA AGGREGATES ELICIT RAPID IMMUNOLOGIC RESPONSE AND PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS. Neuro-Oncology. 25(Supplement_5). v63–v63. 2 indexed citations
11.
Ligon, John A., Jacqueline Y. Maher, Toni Foley, et al.. (2022). Fertility and CAR T-cells: Current practice and future directions. Transplantation and Cellular Therapy. 28(9). 605.e1–605.e8. 20 indexed citations
12.
Ligon, John A., Seth M. Steinberg, Toni Foley, et al.. (2022). The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes. Blood Advances. 6(23). 6040–6050. 25 indexed citations
13.
Gustafson, Michael P., et al.. (2022). Emerging frontiers in immuno- and gene therapy for cancer. Cytotherapy. 25(1). 20–32. 13 indexed citations
14.
Yates, Bonnie, Alexander Ling, Constance M. Yuan, et al.. (2021). Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy. Blood Advances. 6(7). 2167–2182. 35 indexed citations
15.
Masih, Katherine E., John A. Ligon, Bonnie Yates, et al.. (2021). Consequences of hemophagocytic lymphohistiocytosis‐like cytokine release syndrome toxicities and concurrent bacteremia. Pediatric Blood & Cancer. 68(10). e29247–e29247. 10 indexed citations
16.
Sabharwal, Samir, Shivani Ahlawat, Adam S. Levin, et al.. (2020). Desmoid tumor mimics local recurrence of extremity sarcoma on MRI. Journal of Surgical Oncology. 121(8). 1259–1265. 4 indexed citations
17.
Ligon, John A., Janna M. Journeycake, Shellie Josephs, et al.. (2018). Evaluation and Management of Deep Venous Thrombosis Associated with Acute Hematogenous Osteomyelitis in Children. PEDIATRICS. 142. 280–280. 1 indexed citations
18.
Ligon, John A., et al.. (2018). Differentiation of Deep Venous Thrombosis Among Children With or Without Osteomyelitis. Journal of Pediatric Orthopaedics. 38(10). e597–e603. 11 indexed citations
19.
Ligon, John A., Sheldon L. Kaplan, Kristina G. Hultén, Edward O. Mason, & J. Chase McNeil. (2014). Staphylococcus Aureus Bacteremia Without a Localizing Source in Pediatric Patients. The Pediatric Infectious Disease Journal. 33(5). e132–e134. 15 indexed citations
20.
McNeil, J. Chase, John A. Ligon, Kristina G. Hultén, et al.. (2013). Staphylococcus aureus Infections in Children With Congenital Heart Disease. Journal of the Pediatric Infectious Diseases Society. 2(4). 337–344. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026